← back to search

Dennis A. Wigle

Mayo Clinic · US
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Esophageal Cancer Research and Treatment, and Lung Cancer Research Studies.
h-index
68
citations
25,474
works
459
NIH funding
primary concept
Medicine
email

Recent publications

Risk factors and survival associated with lung cancer recurrence after curative-intent surgery: beyond TNM pathological staging.
2025cited by 0position: contributordoi
The 2023 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Management of subsolid lung nodules
Journal of Thoracic and Cardiovascular Surgery 2024cited by 48position: middledoi
Recurrence of Non–Small Cell Lung Cancer With Visceral Pleural Invasion
JAMA Oncology 2024cited by 22position: middledoi
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
New England Journal of Medicine 2023cited by 979position: middledoi
Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non–small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)
Journal of Thoracic and Cardiovascular Surgery 2023cited by 111position: middledoi
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)
JAMA Oncology 2022cited by 52position: middledoi
Integration of Immunotherapy into Adjuvant Therapy for Resected Non-Small-Cell Lung Cancer: ALCHEMIST Chemo-Io (ACCIO)
Immunotherapy 2021cited by 26position: middledoi
Minimally invasive thymectomy for myasthenia gravis favours left-sided approach and low severity class
European Journal of Cardio-Thoracic Surgery 2021cited by 22position: middledoi
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)
The Lancet Respiratory Medicine 2018cited by 379position: middledoi
Progress in the Management of Early-Stage Non–Small Cell Lung Cancer in 2017
Journal of Thoracic Oncology 2018cited by 38position: middledoi
External validation of the Ferguson pulmonary risk score for predicting major pulmonary complications after oesophagectomy
European Journal of Cardio-Thoracic Surgery 2015cited by 30position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Thomas E. Stinchcombe · Duke University6 papers (2018–2024)David R. Jones · Concepts to Systems (United States)5 papers (2018–2024)David Kozono · Harvard University4 papers (2021–2024)Robert J. Keenan · Cork University Hospital4 papers (2018–2024)Ahmad S. Ashrafi · Surrey Memorial Hospital4 papers (2018–2024)Moïshe Liberman · Centre Hospitalier de l’Université de Montréal4 papers (2018–2024)John D. Mitchell · Michigan State University4 papers (2018–2024)Massimo Conti · Université du Québec4 papers (2018–2024)Nasser K. Altorki · Cornell University4 papers (2018–2024)Suresh S. Ramalingam · Emory University3 papers (2018–2022)Daniel Miller · University of Pittsburgh Medical Center3 papers (2018–2023)Thomas Bauer · Comprehensive Cancer Center Vienna3 papers (2023–2024)Karen Kelly · Thomas Jefferson University2 papers (2021–2022)Rodney J. Landreneau · Tampa General Hospital2 papers (2023–2024)Harvey I. Pass · NYU Langone Health2 papers (2018–2023)Xiaofei Wang · UCSF Helen Diller Family Comprehensive Cancer Center2 papers (2018–2023) · 2 papers (2023–2024)Sumithra J. Mandrekar · Mayo Clinic2 papers (2021–2022)Stephen C. Yang · Johns Hopkins University2 papers (2023–2024)Shauna L. Hillman · University of Virginia2 papers (2021–2022)